Ask OpenScientist

Ask a research question about COXFA4-Related COX Deficiency. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

4
Pathophys.
3
Phenotypes
6
Pathograph
1
Genes
1
Medical Actions
3
References

Pathophysiology

4
COXFA4/NDUFA4 Subunit Loss and Failed Complex IV Assembly
Biallelic loss-of-function variants in COXFA4 (formerly NDUFA4) abolish steady-state levels of the COXFA4/NDUFA4 polypeptide, a nuclear-encoded subunit of cytochrome c oxidase. Although the protein was long attributed to Complex I, it is a stoichiometric component of the individual COX complex, and its loss destabilizes the holoenzyme, producing an isolated Complex IV biogenesis defect rather than a Complex I deficiency.
mitochondrial respiratory chain complex IV assembly GO:0033617 ↓ DECREASED
Show evidence (3 references)
PMID:23746447 SUPPORT Human Clinical
"affected individuals harbored homozygous splice donor site mutations in NDUFA4, a gene previously assigned to encode a mitochondrial respiratory chain complex I (NADH:ubiquinone oxidoreductase) subunit."
Identifies homozygous NDUFA4 (COXFA4) loss-of-function mutations as the molecular lesion in this isolated COX deficiency.
PMID:23746447 SUPPORT In Vitro
"Western blot analysis of denaturing gels and immunocytochemistry revealed undetectable steady-state NDUFA4 protein levels, indicating that the mutation causes a loss-of-function effect in the homozygous state."
Demonstrates the variants abolish the subunit protein, establishing a loss-of-function mechanism.
PMID:29636225 SUPPORT Other
"it was demonstrated that NDUFA4, a polypeptide previously attributed to mitochondrial Complex I, was a 14th subunit of COX."
Establishes COXFA4/NDUFA4 as a subunit of Complex IV, so its loss impairs Complex IV biogenesis.
Impaired Terminal Electron Transfer and ATP Synthesis
Loss of COXFA4/NDUFA4 reduces the amount and activity of assembled Complex IV, blocking electron transfer from cytochrome c to molecular oxygen and the coupled proton pumping that drives oxidative ATP synthesis. Complex IV activity was significantly reduced in patient-derived cells.
mitochondrial electron transport, cytochrome c to oxygen GO:0006123 ↓ DECREASED ATP synthesis coupled electron transport GO:0042775 ↓ DECREASED
Show evidence (1 reference)
PMID:38674434 SUPPORT In Vitro
"NDUFA4 encodes for a subunit of the respiratory chain Complex IV, whose activity was significantly reduced in the patient's fibroblasts."
Reduced Complex IV enzymatic activity in patient fibroblasts establishes the functional terminal-electron-transfer deficit.
Lactic Acidosis and Metabolic Decompensation
The block in oxidative phosphorylation shifts energy production toward anaerobic glycolysis, generating lactic acidosis, a characteristic biochemical hallmark of the disorder reported in an affected patient.
lactate biosynthetic process GO:0019249 ↑ INCREASED
Show evidence (1 reference)
PMID:38674434 SUPPORT Human Clinical
"psychomotor delay and white matter signal changes affecting several brain regions, including the brainstem, in addition to lactic and phytanic acidosis, compatible with Leigh syndrome"
The reported patient had lactic acidosis accompanying the Leigh-syndrome presentation.
High-Energy Tissue Dysfunction
The bioenergetic deficit manifests predominantly in the central nervous system, the highest-energy-demand tissue, producing a Leigh-syndrome phenotype: subacute psychomotor delay/regression with bilateral, often brainstem-involving, white-matter signal changes. The two reported families had a relatively mild Leigh syndrome course.
aerobic respiration GO:0009060 ↓ DECREASED
Show evidence (2 references)
PMID:23746447 SUPPORT Human Clinical
"a consanguineous pedigree with isolated COX deficiency linked to a Leigh syndrome neurological phenotype"
The founding pedigree had an isolated COX deficiency presenting as a Leigh syndrome neurological phenotype.
PMID:38674434 SUPPORT Human Clinical
"dysfunction of NDUFA4 was previously documented as causing mitochondrial Complex IV deficiency nuclear type 21 (MC4DN21, OMIM 619065), a relatively mild form of Leigh syndrome."
Confirms MC4DN21 as a relatively mild Leigh syndrome caused by COXFA4/NDUFA4 dysfunction.

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for COXFA4-Related COX Deficiency Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.

Phenotypes

3
Metabolism 1
Lactic acidosis Lactic acidosis HP:0003128
Show evidence (1 reference)
PMID:38674434 SUPPORT Human Clinical
"in addition to lactic and phytanic acidosis, compatible with Leigh syndrome"
The reported patient had lactic acidosis as part of the Leigh-syndrome biochemical profile.
Nervous System 2
Global developmental delay Global developmental delay HP:0001263
Onset: INFANTILE
Show evidence (1 reference)
PMID:38674434 SUPPORT Human Clinical
"a 4-year-old female presenting from early childhood with psychomotor delay"
The reported patient presented with psychomotor delay from early childhood.
Leukoencephalopathy Leukoencephalopathy HP:0002352
Show evidence (1 reference)
PMID:38674434 SUPPORT Human Clinical
"white matter signal changes affecting several brain regions, including the brainstem"
Multifocal white-matter signal changes including the brainstem establish the leukoencephalopathy.
🧬

Genetic Associations

1
COXFA4 (NDUFA4) pathogenic variants causing MC4DN21
Gene: COXFA4 hgnc:7687
Autosomal recessive
Show evidence (2 references)
PMID:23746447 SUPPORT Human Clinical
"affected individuals harbored homozygous splice donor site mutations in NDUFA4, a gene previously assigned to encode a mitochondrial respiratory chain complex I (NADH:ubiquinone oxidoreductase) subunit."
Establishes biallelic NDUFA4 (COXFA4) splice-site mutations as the genetic cause.
PMID:38674434 SUPPORT Human Clinical
"Whole genome sequencing of the family trio identified a homozygous 12.9 Kb deletion, entirely overlapping the NDUFA4 gene."
A second, independent biallelic loss-of-function mechanism (homozygous whole-gene deletion) confirms the gene-disease relationship.
💊

Medical Actions

1
Supportive and Multidisciplinary Care
Action: supportive care MAXO:0000950
No disease-modifying therapy exists; management is supportive and multidisciplinary, addressing the neurological manifestations of the Leigh-syndrome phenotype and metabolic decompensation.
{ }

Source YAML

click to show
name: COXFA4-Related COX Deficiency
category: Mendelian
creation_date: "2026-06-24T00:00:00Z"
synonyms:
- COXFA4 deficiency
- NDUFA4 deficiency
- Mitochondrial complex IV deficiency, nuclear type 21
- MC4DN21
- COXFA4-related cytochrome c oxidase deficiency
- NDUFA4-related Leigh syndrome
description: >
  COXFA4-related COX deficiency (mitochondrial complex IV deficiency nuclear
  type 21, MC4DN21) is an ultra-rare autosomal recessive nuclear form of
  isolated cytochrome c oxidase (COX, Complex IV) deficiency caused by biallelic
  loss-of-function variants in COXFA4 (HGNC-approved current symbol; the gene was
  formerly named NDUFA4 and is still widely referred to by that name in the
  clinical literature and in OMIM). COXFA4/NDUFA4 was historically misassigned as
  a Complex I (NADH:ubiquinone oxidoreductase) subunit, but work from 2012 onward
  established it as a stoichiometric 14th subunit of cytochrome c oxidase, which
  motivated its renaming to COX subunit FA4 (COXFA4). Loss of the subunit
  destabilizes the holoenzyme and produces an isolated Complex IV deficiency.
  The disorder was first defined by Pitceathly et al. (2013), who identified
  homozygous NDUFA4 splice-donor-site mutations in a consanguineous pedigree with
  isolated COX deficiency presenting as a Leigh syndrome neurological phenotype,
  and a second unrelated patient with a homozygous deletion of the gene was later
  reported (Misceo et al., 2024) with psychomotor delay, multifocal white-matter
  changes including the brainstem, and lactic acidosis, again compatible with a
  relatively mild Leigh syndrome. It conforms to the conserved Complex IV
  assembly-deficiency mechanism, with the lesion localized to a destabilized
  nuclear-encoded structural subunit.
disease_term:
  preferred_term: COXFA4-related COX deficiency (MC4DN21)
  term:
    id: MONDO:0033656
    label: mitochondrial complex IV deficiency, nuclear type 21
parents:
- Mitochondrial Disease
- Inborn Error of Metabolism
references:
- reference: PMID:23746447
  title: "NDUFA4 mutations underlie dysfunction of a cytochrome c oxidase subunit linked to human neurological disease."
- reference: PMID:29636225
  title: "NDUFA4 (Renamed COXFA4) Is a Cytochrome-c Oxidase Subunit."
- reference: PMID:38674434
  title: "Biallelic NDUFA4 Deletion Causes Mitochondrial Complex IV Deficiency in a Patient with Leigh Syndrome."
pathophysiology:
- name: COXFA4/NDUFA4 Subunit Loss and Failed Complex IV Assembly
  conforms_to: "complex_iv_assembly_deficiency#Complex IV Biogenesis Failure"
  description: >
    Biallelic loss-of-function variants in COXFA4 (formerly NDUFA4) abolish
    steady-state levels of the COXFA4/NDUFA4 polypeptide, a nuclear-encoded
    subunit of cytochrome c oxidase. Although the protein was long attributed to
    Complex I, it is a stoichiometric component of the individual COX complex,
    and its loss destabilizes the holoenzyme, producing an isolated Complex IV
    biogenesis defect rather than a Complex I deficiency.
  biological_processes:
  - preferred_term: mitochondrial respiratory chain complex IV assembly
    term:
      id: GO:0033617
      label: mitochondrial respiratory chain complex IV assembly
    modifier: DECREASED
  evidence:
  - reference: PMID:23746447
    reference_title: "NDUFA4 mutations underlie dysfunction of a cytochrome c oxidase subunit linked to human neurological disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "affected individuals harbored homozygous splice donor site mutations in NDUFA4, a gene previously assigned to encode a mitochondrial respiratory chain complex I (NADH:ubiquinone oxidoreductase) subunit."
    explanation: Identifies homozygous NDUFA4 (COXFA4) loss-of-function mutations as the molecular lesion in this isolated COX deficiency.
  - reference: PMID:23746447
    reference_title: "NDUFA4 mutations underlie dysfunction of a cytochrome c oxidase subunit linked to human neurological disease."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "Western blot analysis of denaturing gels and immunocytochemistry revealed undetectable steady-state NDUFA4 protein levels, indicating that the mutation causes a loss-of-function effect in the homozygous state."
    explanation: Demonstrates the variants abolish the subunit protein, establishing a loss-of-function mechanism.
  - reference: PMID:29636225
    reference_title: "NDUFA4 (Renamed COXFA4) Is a Cytochrome-c Oxidase Subunit."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "it was demonstrated that NDUFA4, a polypeptide previously attributed to mitochondrial Complex I, was a 14th subunit of COX."
    explanation: Establishes COXFA4/NDUFA4 as a subunit of Complex IV, so its loss impairs Complex IV biogenesis.
  downstream:
  - target: Impaired Terminal Electron Transfer and ATP Synthesis
    causal_link_type: DIRECT
    description: Destabilization of the holoenzyme yields a catalytically deficient Complex IV.
- name: Impaired Terminal Electron Transfer and ATP Synthesis
  conforms_to: "complex_iv_assembly_deficiency#Impaired Terminal Electron Transfer and ATP Synthesis"
  description: >
    Loss of COXFA4/NDUFA4 reduces the amount and activity of assembled Complex
    IV, blocking electron transfer from cytochrome c to molecular oxygen and the
    coupled proton pumping that drives oxidative ATP synthesis. Complex IV
    activity was significantly reduced in patient-derived cells.
  biological_processes:
  - preferred_term: mitochondrial electron transport, cytochrome c to oxygen
    term:
      id: GO:0006123
      label: mitochondrial electron transport, cytochrome c to oxygen
    modifier: DECREASED
  - preferred_term: ATP synthesis coupled electron transport
    term:
      id: GO:0042775
      label: mitochondrial ATP synthesis coupled electron transport
    modifier: DECREASED
  evidence:
  - reference: PMID:38674434
    reference_title: "Biallelic NDUFA4 Deletion Causes Mitochondrial Complex IV Deficiency in a Patient with Leigh Syndrome."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: "NDUFA4 encodes for a subunit of the respiratory chain Complex IV, whose activity was significantly reduced in the patient's fibroblasts."
    explanation: Reduced Complex IV enzymatic activity in patient fibroblasts establishes the functional terminal-electron-transfer deficit.
  downstream:
  - target: Lactic Acidosis and Metabolic Decompensation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Impaired oxidative ATP synthesis forces anaerobic glycolysis, raising lactate.
  - target: High-Energy Tissue Dysfunction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The bioenergetic deficit injures high-demand CNS tissue, producing the Leigh-syndrome neurological phenotype.
- name: Lactic Acidosis and Metabolic Decompensation
  conforms_to: "complex_iv_assembly_deficiency#Lactic Acidosis and Metabolic Decompensation"
  description: >
    The block in oxidative phosphorylation shifts energy production toward
    anaerobic glycolysis, generating lactic acidosis, a characteristic
    biochemical hallmark of the disorder reported in an affected patient.
  biological_processes:
  - preferred_term: lactate biosynthetic process
    term:
      id: GO:0019249
      label: lactate biosynthetic process
    modifier: INCREASED
  evidence:
  - reference: PMID:38674434
    reference_title: "Biallelic NDUFA4 Deletion Causes Mitochondrial Complex IV Deficiency in a Patient with Leigh Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "psychomotor delay and white matter signal changes affecting several brain regions, including the brainstem, in addition to lactic and phytanic acidosis, compatible with Leigh syndrome"
    explanation: The reported patient had lactic acidosis accompanying the Leigh-syndrome presentation.
  downstream:
  - target: High-Energy Tissue Dysfunction
    causal_link_type: DIRECT
    description: Systemic metabolic decompensation compounds the energy deficit in the CNS.
- name: High-Energy Tissue Dysfunction
  conforms_to: "complex_iv_assembly_deficiency#High-Energy Tissue Dysfunction"
  description: >
    The bioenergetic deficit manifests predominantly in the central nervous
    system, the highest-energy-demand tissue, producing a Leigh-syndrome
    phenotype: subacute psychomotor delay/regression with bilateral, often
    brainstem-involving, white-matter signal changes. The two reported families
    had a relatively mild Leigh syndrome course.
  biological_processes:
  - preferred_term: aerobic respiration
    term:
      id: GO:0009060
      label: aerobic respiration
    modifier: DECREASED
  evidence:
  - reference: PMID:23746447
    reference_title: "NDUFA4 mutations underlie dysfunction of a cytochrome c oxidase subunit linked to human neurological disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a consanguineous pedigree with isolated COX deficiency linked to a Leigh syndrome neurological phenotype"
    explanation: The founding pedigree had an isolated COX deficiency presenting as a Leigh syndrome neurological phenotype.
  - reference: PMID:38674434
    reference_title: "Biallelic NDUFA4 Deletion Causes Mitochondrial Complex IV Deficiency in a Patient with Leigh Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "dysfunction of NDUFA4 was previously documented as causing mitochondrial Complex IV deficiency nuclear type 21 (MC4DN21, OMIM 619065), a relatively mild form of Leigh syndrome."
    explanation: Confirms MC4DN21 as a relatively mild Leigh syndrome caused by COXFA4/NDUFA4 dysfunction.
  downstream:
  - target: Global developmental delay
    causal_link_type: DIRECT
    description: CNS energy failure manifests as psychomotor/developmental delay.
  - target: Leukoencephalopathy
    causal_link_type: DIRECT
    description: Bilateral white-matter injury manifests as leukoencephalopathy on neuroimaging.
phenotypes:
- name: Global developmental delay
  description: >
    Psychomotor (developmental) delay from early childhood, part of the
    Leigh-syndrome presentation of COXFA4/NDUFA4 deficiency.
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
    onset:
      onset_category: INFANTILE
  evidence:
  - reference: PMID:38674434
    reference_title: "Biallelic NDUFA4 Deletion Causes Mitochondrial Complex IV Deficiency in a Patient with Leigh Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "a 4-year-old female presenting from early childhood with psychomotor delay"
    explanation: The reported patient presented with psychomotor delay from early childhood.
- name: Lactic acidosis
  description: >
    Lactic acidosis reflecting the shift to anaerobic glycolysis from impaired
    oxidative phosphorylation.
  phenotype_term:
    preferred_term: Lactic acidosis
    term:
      id: HP:0003128
      label: Lactic acidosis
  evidence:
  - reference: PMID:38674434
    reference_title: "Biallelic NDUFA4 Deletion Causes Mitochondrial Complex IV Deficiency in a Patient with Leigh Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "in addition to lactic and phytanic acidosis, compatible with Leigh syndrome"
    explanation: The reported patient had lactic acidosis as part of the Leigh-syndrome biochemical profile.
- name: Leukoencephalopathy
  description: >
    Bilateral white-matter signal changes affecting several brain regions,
    including the brainstem, on neuroimaging — the radiological hallmark of the
    Leigh-syndrome phenotype.
  phenotype_term:
    preferred_term: Leukoencephalopathy
    term:
      id: HP:0002352
      label: Leukoencephalopathy
  evidence:
  - reference: PMID:38674434
    reference_title: "Biallelic NDUFA4 Deletion Causes Mitochondrial Complex IV Deficiency in a Patient with Leigh Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "white matter signal changes affecting several brain regions, including the brainstem"
    explanation: Multifocal white-matter signal changes including the brainstem establish the leukoencephalopathy.
genetic:
- name: COXFA4 (NDUFA4) pathogenic variants causing MC4DN21
  gene_term:
    preferred_term: COXFA4
    term:
      id: hgnc:7687
      label: NDUFA4
  inheritance:
  - name: Autosomal recessive
    evidence:
    - reference: PMID:23746447
      reference_title: "NDUFA4 mutations underlie dysfunction of a cytochrome c oxidase subunit linked to human neurological disease."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "affected individuals harbored homozygous splice donor site mutations in NDUFA4"
      explanation: Homozygous variants in a consanguineous pedigree establish autosomal recessive inheritance.
  features: >
    Biallelic loss-of-function COXFA4 (NDUFA4) variants cause MC4DN21. The
    founding family carried homozygous splice-donor-site mutations causing
    undetectable steady-state protein; a later unrelated patient was homozygous
    for a ~12.9 kb deletion entirely overlapping the gene, likely mediated by
    flanking Alu elements. The gene's HGNC-approved current symbol is COXFA4; it
    is identified as NDUFA4 in OMIM (MC4DN21, OMIM:619065) and in the founding
    clinical reports.
  evidence:
  - reference: PMID:23746447
    reference_title: "NDUFA4 mutations underlie dysfunction of a cytochrome c oxidase subunit linked to human neurological disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "affected individuals harbored homozygous splice donor site mutations in NDUFA4, a gene previously assigned to encode a mitochondrial respiratory chain complex I (NADH:ubiquinone oxidoreductase) subunit."
    explanation: Establishes biallelic NDUFA4 (COXFA4) splice-site mutations as the genetic cause.
  - reference: PMID:38674434
    reference_title: "Biallelic NDUFA4 Deletion Causes Mitochondrial Complex IV Deficiency in a Patient with Leigh Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Whole genome sequencing of the family trio identified a homozygous 12.9 Kb deletion, entirely overlapping the NDUFA4 gene."
    explanation: A second, independent biallelic loss-of-function mechanism (homozygous whole-gene deletion) confirms the gene-disease relationship.
treatments:
- name: Supportive and Multidisciplinary Care
  description: >
    No disease-modifying therapy exists; management is supportive and
    multidisciplinary, addressing the neurological manifestations of the
    Leigh-syndrome phenotype and metabolic decompensation.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
📚

References & Deep Research

References

3
NDUFA4 mutations underlie dysfunction of a cytochrome c oxidase subunit linked to human neurological disease.
No top-level findings curated for this source.
NDUFA4 (Renamed COXFA4) Is a Cytochrome-c Oxidase Subunit.
No top-level findings curated for this source.
Biallelic NDUFA4 Deletion Causes Mitochondrial Complex IV Deficiency in a Patient with Leigh Syndrome.
No top-level findings curated for this source.